Latest Balance Sheet News

Centuria Office REIT has delivered a strong half-year performance with increased portfolio valuation and reaffirmed full-year guidance, while strategically divesting a key asset at a premium.

Ariana Resources has extinguished its outstanding US$782,575 loan with RiverFort by issuing over 40 million shares, leaving the company debt-free and well-capitalised with A$11 million in cash.

Charter Hall Social Infrastructure REIT (CQE) has reported robust first-half FY26 results, driven by strategic acquisitions and strong rental growth, prompting an upgrade to its full-year earnings and distribution guidance.

Ore Resources has identified a significant 2km gold-in-soils anomaly at its Miriam Project in Western Australia, highlighting multiple high-priority targets ahead of a major drilling campaign.

Jumbo Interactive’s preliminary 1H26 results reveal robust double-digit growth driven by SaaS and Managed Services, despite a quieter jackpot landscape. The recent acquisitions in the UK and US add momentum but introduce new accounting complexities.

Vitrafy Life Sciences has delivered key milestones in the first half of FY26, including a strategic partnership with IMV Technologies and progress in clinical studies, while maintaining a strong cash position to support its U.S. expansion and product launches.

Synlait Milk Limited reveals a challenging first half of 2026 with significant losses expected, as it pivots its operations around Canterbury following the upcoming sale of its North Island assets.

Pinnacle Investment Management reported an 11% drop in net profit after tax for the first half of FY26, despite record net inflows and a strategic move to fully acquire Pacific Asset Management.

Pinnacle Investment Management reported a solid 13% increase in funds under management to $202.5 billion despite an 11% drop in half-year profit. The company declared a 29 cent interim dividend and advanced its international expansion with key acquisitions.

Ryman Healthcare has unveiled a refreshed strategy focused on growing recurring earnings and optimising its portfolio, targeting a $150 million sustainable cash flow improvement and $500 million cash release by FY29. The company plans to resume dividends from FY28, underpinned by a resilient balance sheet and disciplined capital management.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Lode Resources is progressing its high-grade silver, antimony, gold, and tin projects in Tasmania and New South Wales, highlighted by robust drilling results and promising metallurgical tests. The company is advancing towards resource estimation and pilot production at Montezuma while expanding exploration across multiple targets.